We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current EBS market cap is 132.11M. The company's latest EPS is USD -4.3199 and P/E is -11.94.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 242.7M | 240M | 330.7M | 165.1M | 337.9M |
| Operating Income | -72M | -42M | -65.1M | -148.1M | 13.8M |
| Net Income | -56.4M | -75.7M | -88M | -183M | -261.3M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 782.4M | 1.11B | 1.56B | 1.79B | 1.12B |
| Operating Income | 89.8M | 114.1M | 433.8M | 352.6M | -172.7M |
| Net Income | 62.7M | 54.5M | 305.1M | 230.9M | -223.8M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.74B | 2.91B | 3.17B | 2.95B | 2.18B |
| Total Liabilities | 1.22B | 1.46B | 1.78B | 1.75B | 1.22B |
| Total Equity | 1.51B | 1.45B | 1.38B | 1.2B | 956.3M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.23B | 2.33B | 2.88B | 2.96B | 3.17B |
| Total Liabilities | 1.22B | 1.24B | 1.44B | 1.34B | 1.78B |
| Total Equity | 1.01B | 1.09B | 1.45B | 1.62B | 1.38B |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -52.9M | -126.9M | -34.1M | -184M | -298.4M |
| Investing | -64.3M | -335.9M | -381.3M | -15.1M | 242.6M |
| Financing | -101.2M | 128.1M | 481.2M | -10.5M | -497.4M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 41.8M | 188M | 536M | 321.1M | -34.1M |
| Investing | -897.2M | -96.9M | -151M | -225M | -381.3M |
| Financing | 788.7M | -35.9M | 69.5M | -141M | 481.2M |
| Market Cap | 132.11M |
| Price to Earnings Ratio | -11.94 |
| Price to Sales Ratio | 2.38 |
| Price to Cash Ratio | 4.16 |
| Price to Book Ratio | 1.93 |
| Dividend Yield | - |
| Shares Outstanding | 51.81M |
| Average Volume (1 week) | 1.76M |
| Average Volume (1 Month) | 1.44M |
| 52 Week Change | -78.68% |
| 52 Week High | 16.6643 |
| 52 Week Low | 1.81 |
| Spread (Intraday) | 0.12 (4.53%) |
| Company Name | Emergent Biosolutions Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.emergentbiosolutions.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
